Skip to content
10-Q

Quarterly Report

ACTAVIA LIFE SCIENCES, INC.

0001213900-24-014866

← back to feed
Filed
Feb 16, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Feb 16, 2024 771.81M sh
Shares Diluted Q1 2024 · Dec 31, 2023 771.81M sh
Shares Diluted Q1 2024 · Dec 31, 2022 179.98M sh
Operating Cash Flow Q1 2024 · Dec 31, 2023 −$47.29K
Operating Cash Flow Q1 2024 · Dec 31, 2022 −$1.39K
Stockholders Equity Q1 2024 · Dec 31, 2023 −$2.1M
Stockholders Equity Q1 2024 · Sep 30, 2023 −$1.96M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$1.81M
Stockholders Equity Q1 2024 · Sep 30, 2022 −$1.69M
Current Liabilities Q1 2024 · Dec 31, 2023 $2.13M
Current Liabilities Q1 2024 · Sep 30, 2023 $2.05M
Total Assets Q1 2024 · Dec 31, 2023 $26.18K
Total Assets Q1 2024 · Sep 30, 2023 $95.66K
Eps Diluted Q1 2024 · Dec 31, 2023 $0.00
Eps Diluted Q1 2024 · Dec 31, 2022 $0.00
Eps Basic Q1 2024 · Dec 31, 2023 $0.00
Eps Basic Q1 2024 · Dec 31, 2022 $0.00
Sga Expense Q1 2024 · Dec 31, 2023 $106.21K
Sga Expense Q1 2024 · Dec 31, 2022 $104.86K
Rd Expense Q1 2024 · Dec 31, 2023 $18.52K
Rd Expense Q1 2024 · Dec 31, 2022 $17.96K
Net Income Q1 2024 · Dec 31, 2023 −$147.64K
Net Income Q1 2024 · Dec 31, 2022 −$149.84K
Operating Income Q1 2024 · Dec 31, 2023 −$124.73K
Operating Income Q1 2024 · Dec 31, 2022 −$122.81K